» Articles » PMID: 8546422

Long-term Effects of Botulinum Toxin Injections in Spasmodic Dysphonia

Overview
Date 1996 Jan 1
PMID 8546422
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose was to examine whether physiological changes can be found in laryngeal muscles following repeated treatment with botulinum toxin injections in spasmodic dysphonia. Seven patients whose treatment consisted of multiple unilateral thyroarytenoid injections were examined more than 6 months following their most recent botulinum toxin injection fiberoptic laryngoscopy and electromyography. Comparisons were made between injected and contralateral noninjected muscles' motor unit characteristics, muscle activation patterns, and vocal fold movement characteristics. The results demonstrated that motor unit characteristics differed between injected and noninjected muscles and that these differences were greater in patients less than 12 months since last injection. Motor unit duration differences were reduced and motor unit amplitude and numbers of turns were increased in muscles sampled over 1 year after injection. These results suggest that while the physiologic effects of botulinum toxin are reversible, the reinnervation process continues past 12 months following injection.

Citing Articles

The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex.

Rogic Vidakovic M, Gunjaca I, Bukic J, Kosta V, Soda J, Konstantinovic I J Clin Med. 2022; 11(12).

PMID: 35743523 PMC: 9224879. DOI: 10.3390/jcm11123453.


Speech-Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function.

Barkmeier-Kraemer J, Clark H Tremor Other Hyperkinet Mov (N Y). 2017; 7:489.

PMID: 28983422 PMC: 5628324. DOI: 10.7916/D8Z32B30.


Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.

Upile T, Elmiyeh B, Jerjes W, Prasad V, Kafas P, Abiola J Head Face Med. 2009; 5:20.

PMID: 19852852 PMC: 2770450. DOI: 10.1186/1746-160X-5-20.


Treatment for spasmodic dysphonia: limitations of current approaches.

Ludlow C Curr Opin Otolaryngol Head Neck Surg. 2009; 17(3):160-5.

PMID: 19337127 PMC: 2763389. DOI: 10.1097/MOO.0b013e32832aef6f.


Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.

Cannito M, Kahane J, Chorna L Clin Interv Aging. 2008; 3(1):131-51.

PMID: 18488884 PMC: 2544359. DOI: 10.2147/cia.s1416.